B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopenia

Sylvain Audia*, Marzia Rossato, Malika Trad, Maxime Samson, Kim Santegoets, Alexandrine Gautheron, Cornelis Bekker, Olivier Facy, Nicolas Cheynel, Pablo Ortega-Deballon, Mathieu Boulin, Sabine Berthier, Vanessa Leguy-Seguin, Laurent Martin, Marion Ciudad, Nona Janikashvili, Philippe Saas, Timothy Radstake, Bernard Bonnotte

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

B cells are involved in immune thrombocytopenia (ITP) pathophysiology by producing antiplatelet auto-antibodies. However more than a half of ITP patients do not respond to B cell depletion induced by rituximab (RTX). The persistence of splenic T follicular helper cells (TFH) that we demonstrated to be expanded during ITP and to support B cell differentiation and antiplatelet antibody-production may participate to RTX inefficiency. Whereas it is well established that the survival of TFH depends on B cells in animal models, nothing is known in humans yet. To determine the effect of B cell depletion on human TFH, we quantified B cells and TFH in the spleen and in the blood from ITP patients treated or not with RTX. We showed that B cell depletion led to a dramatic decrease in splenic TFH and in CXCL13 and IL-21, two cytokines predominantly produced by TFH. The absolute count of circulating TFH and serum CXCL13 also decreased after RTX treatment, whatever the therapeutic response. Therefore, we showed that the maintenance of TFH required B cells and that TFH are not involved in the inefficiency of RTX in ITP.

Original languageEnglish
Pages (from-to)89-95
Number of pages7
JournalJournal of Autoimmunity
Volume77
DOIs
Publication statusPublished - Feb 2017

Keywords

  • Immune thrombocytopenia
  • Rituximab
  • T follicular helper cells

Fingerprint

Dive into the research topics of 'B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopenia'. Together they form a unique fingerprint.

Cite this